Drugs / naltrexone/bupropion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04531176 | Sep 2020 → Aug 2022 | obesity disorder, type 2 diabetes mellitus | The Cleveland Clinic | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | naltrexone/bupropion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04531176 ↗ |